Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial

NCT02275533 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

NIH

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
OTHER: Clinical Observation
PROCEDURE: Echocardiography Test
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)